However, findings revealed that CD14++ monocytes from CeD patients have significantly higher levels of CD64 expression (p = 0.0352) than CTL along with lower CD33 expression when similarly compared (p = 0.0029). This evidence concerns the gene FCGR1A and cranioectodermal dysplasia.